FDA approves HPV test for first-line screening

Contemporary OB/GYN editorial board member Ilana Cass, MD, offers perspective on the recent FDA approval of the first-ever alternative to Pap smear cytology cervical screening. » More

• The transcervical Foley balloon

• HPV vaccination rate in South lags behind the rest of US

• FDA panel recommends HPV DNA test as first-line screening

POLL

Tell us: Ob/gyns, do you recommend screening mammography to patients aged 40 to 59?

- Yes
- No